PRESSR: Crescent Enterprises awards $100,000 MIT Solve AI for Social Innovation Prize at UN General Assembly Week

• Inaugural prize backs real-world AI solutions in literacy, women’s health, climate resilience, and eyecare

New York / Sharjah – Crescent Enterprises, the UAE-headquartered diversified business, and MIT Solve, the Massachusetts Institute of Technology initiative for technology-led social impact, today announced the inaugural Crescent Enterprises AI for Social Innovation Prize recognizing four outstanding teams applying artificial intelligence to stubborn global challenges.

Unveiled on the sidelines of the United Nations General Assembly and Climate Week in New York, the Crescent Enterprises prize provides $100,000 in equity-free funding and access to MIT Solve’s nine-month Solver support, mentorship, and global networks.

The four recipients are:

• I Read Arabic – advancing Arabic literacy at scale through engaging, high-quality digital learning.
• Smart Scope® CX – bringing low-cost, AI-assisted cervical cancer screening to the point of care.
• Littoral – turning coastal data into early warning and planning tools for climate-resilient shores.
• Visilant – expanding affordable eye screening so more people can see – and thrive - sooner.

“Technology is only as powerful as the impact it creates,” said H.E. Badr Jafar, CEO, Crescent Enterprises. “With these AI-enabled solutions we have a tangible opportunity to tackle challenges once thought intractable – from literacy and healthcare to climate resilience. Our partnership with MIT Solve connects visionary entrepreneurs to the resources they need to turn breakthrough ideas into scalable solutions. At Crescent Enterprises, innovation must be inclusive, sustainable, and anchored in real-world progress.”

“We're thrilled to partner with Crescent Enterprises on the 2025 Crescent Enterprises AI for Social Innovation Prize,” said Hala Hanna, Executive Director of MIT Solve. “This funding will have ripple effects in communities around the world.”

The announcement follows Crescent Enterprises’ co-hosting of the first MIT Challenge Clinic in Arabic, designed to open Solve’s global networks to Arab entrepreneurs and equip them to scale AI-driven innovations more effectively.

MIT Solve’s 2025 Global Challenges distributed over $1.5 million in prize funding to 31 Solver teams selected from a record 2,900 applicants across 130 countries.

About Crescent Enterprises

Crescent Enterprises is a multinational company based in the United Arab Emirates with strategic investments across sectors. Established in 2007, the business comprises a diversified group of 57 subsidiaries, affiliates, and investments across 19 countries, and employs more than 1,600 people. Its four platforms – CE‑Operates, CE‑Invests, CE‑Ventures, and CE‑Creates – span ports and logistics, food and beverages, healthcare, life sciences, business aviation, private equity, venture capital, and business incubation.

Crescent Enterprises is a subsidiary of Crescent Group, a family-owned business shaping the MENA region’s economy for over 50 years. www.crescententerprises.com

For media inquiries please contact:

Charlie Scott, Crescent Enterprises,  cscott@crescent.ae

Ghyna Kurdy, Sahara Communications, g.kurdy@saharapr.com

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.